LOXO LARO 25 mg Pill - white capsule/oblong, 18mm
Generic Name: larotrectinib
Pill with imprint LOXO LARO 25 mg is White, Capsule/Oblong and has been identified as Vitrakvi 25 mg. It is supplied by Loxo Oncology, Inc.
Vitrakvi is used in the treatment of Solid Tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOXO LARO 25 mg
Vitrakvi
- Generic Name
- larotrectinib
- Imprint
- LOXO LARO 25 mg
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Loxo Oncology, Inc.
- National Drug Code (NDC)
- 71777-0390 (Discontinued)
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Trexall
Trexall is used for acute lymphoblastic leukemia, acute lymphocytic leukemia, breast cancer ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Rasuvo
Rasuvo is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Retevmo
Retevmo (selpercatinib) is an oral kinase inhibitor that may be used to treat certain types of ...
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.